Merit Medical Acquires Solo Pace for US$45 Million to Expand Structural Heart Device Portfolio

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in ...

November 02, 2026 | Monday | News
Merit Medical Acquires Solo Pace for US$45 Million to Expand Structural Heart Device Portfolio

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in ...

November 02, 2026 | Monday | News
Merit Medical Acquires Solo Pace for US$45 Million to Expand Structural Heart Device Portfolio

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in ...

November 02, 2026 | Monday | News
American Hospital Dubai Partners with HEI Global Health to Develop AI-Powered Revenue Cycle Platform

American Hospital Dubai ("AHD"), one of the Middle East's premier private healthcare providers and a member of the Mayo Clinic Care Network, and HEI Global...

October 27, 2026 | Tuesday | News
King Faisal Specialist Hospital Expands Cardiac Care with Emergency Catheterisation Lab in Riyadh

What began with a single cardiac catheterization laboratory four decades ago has evolved into an advanced cardiovascular program at King Faisal Specialist ...

October 26, 2026 | Monday | News
SciSparc Highlights NeuroThera’s Quantum Analytics Milestone for Clinical Trial Data

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”),  announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...

August 04, 2026 | Tuesday | News
Idorsia Partners with Jamjoom Pharma to Expand QUVIVIQ Commercialization Across Saudi Arabia and the Levant

Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region ...

July 28, 2026 | Tuesday | News
BioLineRx and Hemispherian Report Promising Preclinical Data for GLIX1-Olaparib Combination in Ovarian Cancer

Synergy was demonstrated in a combination arm of GLIX1 and the PARP inhibitor olaparib at low doses, with substantially better efficacy compared t...

July 10, 2026 | Friday | News
Evogene and Tel Aviv University Launch AI-Driven Small Molecule Drug Discovery Initiative

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the generative design of small molecules for the pharmaceuti...

July 10, 2026 | Friday | News
Abu Dhabi and Biocom California Establish Strategic Gateway Linking Two Leading Life Sciences Ecosystems

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest ...

June 25, 2026 | Thursday | News
Teva Submits NDA for Ecopipam as Potential First-in-Class Treatment for Pediatric Tourette Syndrome

NDA submission supported by positive Phase 3 data recently published in JAMA Neurology. Ecopipam is a first-in-class selective dopamine D1 receptor an...

June 22, 2026 | Monday | News
SERB Pharmaceuticals Acquires European and MENA Rights to Idefirix® from Hansa Biopharma in €115 Million Deal

SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) announced that they have entered into an ...

May 20, 2026 | Wednesday | News
Innovaccer, Infinia Forge Alliance to Accelerate UAE’s Digital Health Transformation

Innovaccer Inc., a leading healthcare AI company, and Infinia Technologies, a next-generation digital transformation company and a subsidiary of Sirius I...

April 10, 2026 | Friday | News
Humacyte Secures $1.475M Symvess Commitment to Advance Clinical Evaluation in Saudi Arabia

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at comme...

March 20, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close